DermTech, Inc. develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. The company sells its products primarily to pathology and oncology practitioners.
Market Cap | 47.719 Million | Shares Outstanding | 5.343 Million | Avg 30-day Volume | 3.115 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -1.5 |
Price to Revenue | 8.1136 | Debt to Equity | 0.0309 | EBITDA | -111.323 Million |
Price to Book Value | 0.769 | Operating Margin | 0.0 | Enterprise Value | 24.998 Million |
Current Ratio | EPS Growth | -0.954 | Quick Ratio | ||
1 Yr BETA | 0.2834 | 52-week High/Low | 0.0 / | Profit Margin | -779.5834 |
Operating Cash Flow Growth | -109.4514 | Altman Z-Score | Free Cash Flow to Firm | 15.44 Million |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
WOOD TODD MICHAEL CHIEF COMMERCIAL OFFICER |
|
215,099 | 2022-09-12 | 4 |
IBARRA CLAUDIA CHIEF OPERATING OFFICER |
|
160,783 | 2022-09-12 | 4 |
SUN KEVIN M CHIEF FINANCIAL OFFICER |
|
222,901 | 2022-09-06 | 1 |
|
4,405 | 2022-07-18 | 2 | |
|
0 | 2022-07-18 | 2 | |
DOBAK JOHN CHIEF EXECUTIVE OFFICER |
|
665,295 | 2022-05-27 | 1 |
|
98,862 | 2022-05-26 | 2 | |
|
69,121 | 2022-05-26 | 1 | |
|
122,501 | 2022-05-26 | 1 | |
|
35,099 | 2022-05-26 | 1 | |
|
33,975 | 2022-05-26 | 1 | |
|
2,887,216 | 2020-08-17 | 0 | |
YAO ZUXU CHIEF SCIENTIFIC OFFICER |
|
84,364 | 2020-06-24 | 0 |
JANSEN BURKHARD CHIEF MEDICAL OFFICER |
|
84,037 | 2020-06-24 | 0 |
|
52,514 | 2020-06-17 | 0 | |
|
1,321,813 | 2020-06-17 | 0 | |
|
819,862 | 2020-06-17 | 0 | |
|
1,808,434 | 2020-05-11 | 0 | |
|
179,154 | 2020-01-30 | 0 | |
|
1,766,502 | 2019-08-29 | 0 | |
KEMPER STEVEN J CHIEF FINANCIAL OFFICER |
|
59,685 | 2019-08-29 | 0 |
|
1,766,502 | 2019-08-29 | 0 | |
|
1,766,502 | 2019-08-29 | 0 | |
|
919,296 | 2019-03-26 | 0 | |
|
No longer subject to file | 2019-03-21 | 0 | |
SHUKLA RAJIV CEO & CHAIRMAN |
|
3,882,500 | 2017-06-23 | 0 |
|
0 | 2017-06-19 | 0 | |
|
0 | 2017-06-19 | 0 | |
POLLAK CRAIG CFO AND SECRETARY |
|
0 | 2017-06-19 | 0 |
|
0 | 2017-06-19 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No current insider transactions |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|
Holder | Issuer | Net Short Position | Position Date | Origin |
---|